Guardion Health Sciences, which sells medical food for age-related macular degeneration and computer vision syndrome, filed on Wednesday with the SEC to raise up to $10 million in an initial public offering.
The San Diego, CA-based company was founded in 2009 and booked $1 million in revenue for the 12 months ended June 30, 2018. It plans to list on the NYSE under the symbol GHSI. Guardion Health Sciences filed confidentially on October 4, 2018. WallachBeth Capital is the sole bookrunner on the deal. No pricing terms were disclosed.
